YahooSeptember 29, 2026 at 9:30 AM NY28 Days Ago
ClearPoint Neuro Shares Fall 24% Following uniQure AMT-130 Trial Update
ClearPoint Neuro (NASDAQ:CLPT) shares fell 24% on Tuesday following updated clinical trial results from partner uniQure N. V.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
